21
2025
-
11
ZLXIDE Series Pharmaceutical Excipients: Empowering Multi-Field Formulation Innovation
It provides key support for multi-field high-end formulations with ultra-high loading and ultra-fine refinement, helping products achieve efficient sustained release and stability.
Article 1: ZLXIDE-P58BT: Vitamin Health Product-Specific Pharmaceutical Excipient Enabling Precise Nutrient Sustained Release
ZLXIDE-P58BT is a pharmaceutical excipient specifically designed for vitamin health product series, integrating three functions: retention aid, adsorbent and sustained-release agent. It boasts excellent technical parameters: particle size of 20μm, specific surface area of 230-300 m²/g, pH range of 6.0-8.0, and moisture content ≤8.5%.
In application scenarios, it serves the vitamin health product series precisely. It can improve the retention rate of vitamin components in formulations, adsorb impurities and achieve sustained release of nutrients, providing core support for the stable efficacy of vitamin health products.
Article 2: ZLXIDE-P244, P58, P350: Multi-Field Pharmaceutical Excipients Covering Pharmaceutical, Food and Cosmetic Needs with Differentiated Performance
ZLXIDE-P244, P58 and P350 are all multi-functional pharmaceutical excipients with retention, adsorption and sustained-release functions. They are widely used in three fields: pharmaceuticals, food and cosmetics, and each model meets segmented needs through differentiated processes and parameters:

•ZLXIDE-P244: Prepared by gel method, with particle size of 8-50μm, specific surface area of 230-300 m²/g, pH of 5.5-7.5 and moisture ≤7.0%. It is suitable for neutral to weakly acidic formulation systems and performs excellently in multi-field general formulations.
•ZLXIDE-P58 & P350: Both have high oil absorption performance and particle size of 8-50μm. Among them, P58 has a specific surface area of 260-300 m²/g, pH of 6.0-8.0 and moisture ≤8.5%; P350 has an increased specific surface area of 260-350 m²/g, with more outstanding adsorption and sustained-release capabilities for oil components, providing efficient solutions for oil-containing formulations.
Article 3: ZLXIDE-P200/P300/P380 Colloidal Silica Series: Nano-Grade Pharmaceutical Excipients Driving High-End Formulation Innovation in Multiple Fields
ZLXIDE-P200, P300 and P380 belong to colloidal silica pharmaceutical excipients. Based on 12nm nano particle size, they integrate retention, adsorption and sustained-release functions, and widely serve high-end fields of pharmaceuticals, food and cosmetics. They achieve precise adaptation through gradient design of specific surface area:
•ZLXIDE-P200 (Colloidal Silica M-5P, A200): Specific surface area of 200±20 m²/g, pH of 3.9-4.5 and moisture ≤2%. It is suitable for scenarios requiring stable component dispersion and moderate interface interaction, such as drug microencapsulation and food additive dispersion.

•ZLXIDE-P300 (Colloidal Silica A300): Specific surface area of 300±20 m²/g, maintaining pH and low moisture characteristics. Its adsorption and loading capacity is upgraded, suitable for high-active pharmaceutical formulations, cosmetic essences and other efficacy-intensive products.
•ZLXIDE-P380 (Colloidal Silica A380): Specific surface area of 380±20 m²/g, the model with the strongest interface interaction in the series. It provides key support for multi-field high-end formulations with ultra-high loading and ultra-fine refinement, helping products achieve efficient sustained release and stability.
Disclaimer
Information about Grace’s products is collected from public sources for reference only. News and information released by Zhonglian Chemical is for professional exchange in the industry, without guarantee of accuracy or completeness. Users shall use this information independently and bear corresponding risks; Zhonglian Chemical assumes no liability for any losses arising from its use. For copyright infringement, please contact us for removal.
Related Blog
Related Downloads

